Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Salivary Gland Infection Market Expansion From $4.8 Billion In 2026 To $6.49 Billion In 2030

The market for salivary gland infections has experienced robust expansion lately. Projections indicate a rise from $4.45 billion in 2025 to $4.81 billion in 2026, reflecting a compound annual growth rate of 8.1%. This upward trend during the historical period is a result of several contributing factors, including a higher prevalence of bacterial and viral infections affecting salivary glands, enhanced accessibility to diagnostic imaging techniques, the widespread availability of broad-spectrum antibiotic treatments, the growth of ear, nose, and throat (ENT) services within hospital settings, and a growing recognition among clinicians regarding disorders of these glands.

Concerning Driver 1, the market for salivary gland infection treatment is poised for considerable expansion, projecting a value of $6.5 billion by the year 2030, underpinned by a compound annual growth rate of 7.8%. This projected surge is anticipated to be fueled by a confluence of factors including a heightened requirement for precise diagnostic capabilities, augmented investments directed towards otorhinolaryngology diagnostic instrumentation, the proliferation of ambulatory diagnostic facilities, an escalating emphasis on patient-focused therapeutic strategies, and the greater incorporation of both imaging and laboratory-based diagnostics. Key developments expected to shape this period involve the increased utilization of sophisticated imaging diagnostics, the growing acceptance of specific antibiotic treatments, a heightened focus on the prompt identification of infections, the broader implementation of less invasive therapeutic interventions, and a more pronounced dedication to thorough diagnostic methodologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp

Salivary Gland Infection Market Growth Factors Supporting Long-Term Expansion

The escalating prevalence of oral health concerns is poised to propel the expansion of the salivary gland infections market. Conditions such as cavities, periodontal disease, and other oral ailments fall under the umbrella of oral health issues, which are exacerbated by suboptimal dental hygiene, detrimental dietary patterns, and limited access to professional dental services. An increase in these oral health problems heightens the susceptibility to salivary gland infections, as they foster bacterial proliferation and obstruct salivary ducts. For illustration, data from the National Health Service (NHS) in the UK indicates that during the 2022-23 period, 32.5 million dental treatments were administered, representing a 23.2% uptick from the preceding year. Consequently, the advancement of oral health difficulties serves as a significant catalyst for the growth of the salivary gland infections market.

The increasing adoption of minimally invasive surgical techniques is anticipated to be a key driver for the salivary gland infections market. This surgical approach involves making small incisions and employing specialized instruments to conduct procedures, resulting in reduced discomfort, quicker recuperation, and less noticeable scarring compared to traditional open surgery. The appeal of minimally invasive surgery stems from its inherent benefits, including diminished pain, accelerated recovery times, and a lower incidence of complications, further bolstered by technological innovations like robotics and laparoscopic devices that enhance procedural accuracy and patient outcomes. These less invasive methods are applied to treat salivary gland infections by creating tiny openings to drain abscesses or remove obstructions, thereby minimizing recovery periods and potential adverse events. As an example, the American Society of Plastic Surgeons, a US-based nonprofit, noted in June 2024 that minimally invasive procedures experienced a 7% rise in 2023 compared to the previous year. Therefore, the escalating demand for minimally invasive surgery is positively influencing the trajectory of the salivary gland infections market.

Salivary Gland Infection Market Segment Breakdown: Which Categories Generate The Most Revenue?

The salivary gland infection market covered in this report is segmented –

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses

2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments

3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray

2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

Salivary Gland Infection Market Industry Trends Shaping Future Revenue Growth

Within the salivary gland infections sector, key players are focusing on embracing technological progress, especially concerning less invasive treatment methods, aiming to elevate patient recovery, hasten healing periods, and boost the effectiveness of medical care. These less invasive approaches utilize reduced incisions and specialized instruments, resulting in minimized tissue trauma and facilitating swifter recuperation. As an illustration, a prominent healthcare facility in India, Amrita Hospital, unveiled the Amrita Centre for minimally invasive salivary gland surgery in March 2024, introducing an innovative therapeutic option for salivary gland ailments via endoscopy. This advancement substantially decreases the necessity for surgical intervention while safeguarding the gland’s functionality. The inauguration was further spotlighted by a two-day instructional event featuring demonstrations by seasoned professionals.

Salivary Gland Infection Market Key Players And Strategic Industry Positioning

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc

Access The Complete Salivary Gland Infection Market Report:

https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

Salivary Gland Infection Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the salivary gland infection market in 2025. The regions covered in the salivary gland infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.